Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 805705, 11 pages
http://dx.doi.org/10.1155/2013/805705
Review Article

Cyclosporine Regimens in Plaque Psoriasis: An Overview with Special Emphasis on Dose, Duration, and Old and New Treatment Approaches

1Novartis Farma S.p.A., Origgio, Varese, Italy
2Department of Dermatology, Marchesi Hospital, Inzago, Milan, Italy
3Dermatology and Venereology Private Practice, Bari and Barletta, Italy

Received 31 May 2013; Accepted 2 July 2013

Academic Editors: H. Fujita and I. Neri

Copyright © 2013 M. D. Colombo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Reviriego, “Phosphodiesterase PDE4 inhibitor treatment of atopic dermatitis treatment of psoriasis,” Drugs of the Future, vol. 39, no. 9, pp. 607–613, 2014. View at Publisher · View at Google Scholar
  • C. Reviriego, “AN-2728 Phosphodiesterase PDE4 inhibitor Treatment of atopic dermatitis Treatment of psoriasis,” Drugs of The Future, vol. 39, no. 9, pp. 607–613, 2014. View at Publisher · View at Google Scholar
  • Catherine Ni, and Melvin W. Chiu, “Psoriasis and comorbidities: Links and risks,” Clinical, Cosmetic and Investigational Dermatology, vol. 7, pp. 119–132, 2014. View at Publisher · View at Google Scholar
  • Beatrice Marinoni, Angela Ceribelli, Marco S. Massarotti, and Carlo Selmi, “The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications,” Autoimmunity Highlights, 2014. View at Publisher · View at Google Scholar
  • Anna Sokolova, Andrew Lee, and Saxon D Smith, “The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review,” American Journal of Clinical Dermatology, 2015. View at Publisher · View at Google Scholar
  • Jamie L. Harden, James G. Krueger, and Anne M. Bowcock, “The immunogenetics of Psoriasis: A comprehensive review,” Journal of Autoimmunity, 2015. View at Publisher · View at Google Scholar
  • Tahmina Mahmood, Daniel Zaghi, and Alan Menter, “Emerging oral drugs for psoriasis,” Expert Opinion on Emerging Drugs, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • V.P. Venkatpurwar, S. Rhodes, K.A. Oein, M.A. Elliott, C.D. Tekwe, H.G. Jørgensen, and M.N.V. Ravi Kumar, “Drug- not carrier-dependent haematological and biochemical changes in a repeated dose study of cyclosporine encapsulated polyester nano- and micro-particles: Size does not matter,” Toxicology, 2015. View at Publisher · View at Google Scholar
  • S. Philipp, G. Kokolakis, and R. Sabat, “Systemische Therapien der Psoriasis und Psoriasisarthritis,” Der Hautarzt, 2016. View at Publisher · View at Google Scholar
  • Andrea Chiricozzi, Dante Caposiena, Virginia Garofalo, Maria Vittoria Cannizzaro, Sergio Chimenti, and Rosita Saraceno, “A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast,” Expert Review of Clinical Immunology, vol. 12, no. 3, pp. 237–249, 2016. View at Publisher · View at Google Scholar
  • Antonio Carpentieri, Lucia Pacello, Immacolata Maria De Marco, Anna Loiacono, Orietta Picconi, and Francesco Loconsole, “Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study,” Journal of Dermatological Treatment, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Vidhi V. Shah, Shivani P. Reddy, Elaine J. Lin, and Jashin J. Wu, “Cyclosporine,” Therapy for Severe Psoriasis, pp. 63–73, 2016. View at Publisher · View at Google Scholar
  • Anna Chapman, and Yasser El Miedany, “Psoriasis,” Comorbidity in Rheumatic Diseases, pp. 81–124, 2017. View at Publisher · View at Google Scholar
  • Sharad Mutalik, Swapnil Shah, Varsha Sidwadkar, and Meenaz Khoja, “Efficacy of Cyclosporine After Autologous Noncultured Melanocyte Transplantation in Localized Stable Vitiligo—A Pilot, Open Label, Comparative Study,” Dermatologic Surgery, vol. 43, no. 11, pp. 1339–1347, 2017. View at Publisher · View at Google Scholar
  • Ahmed F. El-Yazbi, Ali H. Eid, and Mahmoud M. El-Mas, “Cardiovascular and renal interactions between cyclosporine and NSAIDs: Underlying mechanisms and clinical relevance,” Pharmacological Research, 2017. View at Publisher · View at Google Scholar
  • Chong Won Choi, Bo Ri Kim, Jungyoon Ohn, and Sang Woong Youn, “The Advantage of Cyclosporine A and Methotrexate Rotational Therapy in Long-Term Systemic Treatment for Chronic Plaque Psoriasis in a Real World Practice,” Annals of Dermatology, vol. 29, no. 1, pp. 55, 2017. View at Publisher · View at Google Scholar
  • Bo Ri Kim, Seungkeol Yang, Eun Jin Doh, Chong Won Choi, and Sang Woong Youn, “Risk Factors Affecting Adverse Effects of Cyclosporine A in a Real-World Psoriasis Treatment,” Annals of Dermatology, vol. 30, no. 2, pp. 143, 2018. View at Publisher · View at Google Scholar